REG - McBride PLC - Second tranche of share buyback programme

McBrideAnnouncement

01/05/2026 07:01

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260501:nRSA6884Ca&default-theme=true

RNS Number : 6884C  McBride PLC  01 May 2026

McBride plc

 

Second tranche of share buyback programme

 

McBride plc (the "Company"), the leading European manufacturer and supplier of
private label and contract manufactured products for the domestic household
and professional cleaning/hygiene markets, today announces the commencement of
the second tranche of its share buyback programme to purchase ordinary shares
of 10 pence each in the Company ("Ordinary Shares"), as launched on 1 December
2025 (the "Programme").

Purchases under the first tranche of the Programme commenced on 1 December
2025 and continued until 30 April 2026. Under the first tranche, between 1
December 2025 and 30 April 2026, the Company repurchased 3,236,565 Ordinary
Shares for an aggregate consideration of approximately £4.5 million.

The Company announces that the second tranche of the Programme of up to £15.5
million (being the balance of the £20 million maximum amount of the Programme
less the aggregate consideration paid under the first tranche of the
Programme) will commence today (the "Second Tranche"). The Second Tranche is
structured in two phases.  In respect of the first phase, the Company has
entered into a non-discretionary agreement with Investec Bank plc ("Investec")
to act as riskless principal in relation to the purchase of Ordinary Shares,
and the subsequent sale of such Ordinary Shares to the Company. The second
phase will be undertaken by Peel Hunt LLP ("Peel Hunt", together with
Investec, the "Brokers"). The Company has entered into a non-discretionary
agreement with Peel Hunt to act as riskless principal in relation to the
purchase of Ordinary Shares, and the subsequent sale of such Ordinary Shares
to the Company.

Purchases of Ordinary Shares under the Second Tranche are expected to commence
on 1 May 2026 and to be completed by no later than 30 September 2026.  The
Company intends to announce any purchases under the Programme on a weekly
basis from the commencement of the Second Tranche of the Programme.

The Brokers will each make trading decisions in relation to the Programme
independently of the Company.  Any purchase of Ordinary Shares by the Brokers
contemplated by this announcement will be carried out on the London Stock
Exchange.  Any purchases of Ordinary Shares by the Company under the
Programme will be carried out on the London Stock Exchange.

The purpose of the Programme is to reduce the share capital of the Company by
returning surplus capital to shareholders. Ordinary Shares purchased under the
Second Tranche will be cancelled. These arrangements are in accordance with
the Company's general authority to repurchase up to 17,401,528 Ordinary
Shares granted at its 2025 Annual General Meeting. The Second Tranche will
also be conducted within certain pre-set parameters, in accordance with
Chapter 9 of the Listing Rules and within the parameters prescribed by the
Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation
(EU) 2016/1052 (both as incorporated into UK domestic law by the European
Union (Withdrawal) Act 2018).

From time to time, the Board will assess the progress of this Programme in
light of the financial situation of the Company and its capital allocation
needs.

For further information, please contact:

 

 McBride plc                               Via TEAM LEWIS
 Chris Smith, Chief Executive Officer
 Mark Strickland, Chief Financial Officer

 TEAM LEWIS                                McBride@teamlewis.com (mailto:McBride@teamlewis.com)
 Hannah Scott                              +44 (0)20 7802 2634

 Galyna Kulachek                           +44 (0)20 7802 2617

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCAKKBPOBKDBQN



            Copyright 2019 Regulatory News Service, all rights reserved